Parkwalk closes Cisiv investment

We are pleased to announce that the Parkwalk Opportunities EIS Fund and the Parkwalk UK Tech Fund V have led a financing round into Cisiv, an innovative and intuitive software platform for late phase pharmaceutical trials. enables pharmaceutical… Read More